EUVIMEDEUVIMED entdecken
Crossref

Benzo[d][1,2]thiazepin-5-one 3-Oxides: An Unexplored Scaffold with Anticancer Activity

Alexey V. Dobrydnev, Demyd S. Milokhov, Mykhailo S. Pomalin, Tetiana M. Lutsiuk, Vasyl Y. Hys, Pavlo A. Virych, Anton O. Poliudov, Maria V. Popova, Svitlana V. Shishkina, Yulian M. Volovenko

Synlett · 01.10.2025 · 36 (16) · 2615-2622

DOI: 10.1055/a-2637-7357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, erschienen am 01.10.2025. Verfasst von Alexey V. Dobrydnev und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Enamine Ltd., Ministry of Education and Science of Ukraine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report a simple and versatile method for the synthesis of previously unknown benzo[d][1,2]thiazepin-5-one 3-oxides through the CSIC (carbanion-mediated sulfonamide intramolecular cyclization) reaction strategy. The starting compounds are readily available methyl 2-(bromomethyl)benzoates and imino((di)methyl)((het)aryl)-λ6-sulfanones. The method works well with a wide range of substrates, proving its applicability for the synthesis of benzo- and heteroarene-fused derivatives. It allows for the effortless preparation of target endocyclic keto sulfoximines and easy scale-up without diminishing the yield. The synthetic utility of the target compounds was demonstrated by the preparation of several derivatives, some of them represented two novel heterocyclic systems. In vitro cytotoxicity assay showed selective cytotoxicity of S-phenyl-substituted benzo[d][1,2]thiazepin-5-one 3-oxide against triple-negative breast cancer cell line MDA-MB-231. The molecular docking study confirmed good binding affinity of both enantiomeric forms of endocyclic keto sulfoximines to the cancer-associated receptors, which are the therapeutic targets in cancer treatment.

Förderung

  • Enamine Ltd.
  • Ministry of Education and Science of Ukraine

Zitieren

APA

Dobrydnev, A. V., Milokhov, D. S., Pomalin, M. S., Lutsiuk, T. M., Hys, V. Y., Virych, P. A., Poliudov, A. O., Popova, M. V., Shishkina, S. V., & Volovenko, Y. M. (2025). Benzo[d][1,2]thiazepin-5-one 3-Oxides: An Unexplored Scaffold with Anticancer Activity. Synlett, 36(16), 2615-2622. https://doi.org/10.1055/a-2637-7357

Vancouver

Dobrydnev AV, Milokhov DS, Pomalin MS, Lutsiuk TM, Hys VY, Virych PA, et al. Benzo[d][1,2]thiazepin-5-one 3-Oxides: An Unexplored Scaffold with Anticancer Activity. Synlett. 2025;36(16):2615-2622. doi:10.1055/a-2637-7357

BibTeX
@article{Dobrydnev2025,
  author = {Dobrydnev, Alexey V. and Milokhov, Demyd S. and Pomalin, Mykhailo S. and Lutsiuk, Tetiana M. and Hys, Vasyl Y. and Virych, Pavlo A. and Poliudov, Anton O. and Popova, Maria V. and Shishkina, Svitlana V. and Volovenko, Yulian M.},
  title = {Benzo[d][1,2]thiazepin-5-one 3-Oxides: An Unexplored Scaffold with Anticancer Activity},
  journal = {Synlett},
  year = {2025},
  volume = {36},
  number = {16},
  pages = {2615--2622},
  doi = {10.1055/a-2637-7357}
}
Kostenlos starten →